Skip to main content
. 2012 Aug 29;23(12):1247–1257. doi: 10.1089/hum.2012.042

FIG. 3.

FIG. 3.

IDLV-Nogo-B reduced VSMC proliferation. (A) IDLV-Nogo-B blocked VSMC proliferation, as assessed with an MTT assay at 5 days post infection. *p<0.001 vs. their LV-eGFP control and uninfected. (B) Representative micrographs (at an MOI of 50). Scale bar, 100 μm. (C) IDLV-Nogo-B did not induce VSMC apoptosis, as demonstrated using a caspase-3/7 activity assay 5 days post-transduction at an MOI of 50.